Multicenter, randomized, double-blind, placebo-controlle

Project: Research project

Project Details

Description

Multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of fulvestrant (faslodex) with or without PD-0332991 (Palbociclib) +/- Goserelin in women with hormone receptor-positive,
StatusActive
Effective start/end date9/1/131/31/21

Funding

  • PFIZER, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.